Thank you for requesting End-of-Life Care: How to Determine the Right Strategy for Mature Brands.

To download a copy of this document, please provide the following basic information:

Leave this field empty
    It's OK to send me occasional emails with new
perspectives from inVentiv Health Consulting

Based on current trends, soon 90 percent of products dispensed will be for a generic. As a result, companies are more aggressively managing their product life cycles. Life cycle planning requires a coordinated effort with respect to understanding the market dynamics, the future trends in markets, and the clinical profile of the brand and where it can be optimized. With a wide range of generic defense strategies and tactics available, however, it can be challenging to decide which tactics make the most sense for a given brand. This article from the June 2015 issue of Med Ad News outlines potential strategies for generic defense and the steps necessary to determine the right path forward.
inVentiv Health Consulting offers world class healthcare consulting services.